Logo

LGC SeraCare Seraseq ctDNA MRD Panel Mix

Jul 09, 2021

LGC Seracare has launched the Seraseq ctDNA MRD Panel Mix reference material designed for use in patient-derived cell-free DNA minimal residual disease next-generation sequencing assays. The product was developed by combining a diseased cell line, its SNP-matched normal cell line, and biosynthetic DNA variants of clinical utility and/or targeted therapeutics, the company noted. The reference material is offered as a purified mutation mix ready for sequencing library prep with no additional extraction or purification step, according to the company.

Breaking News
The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.